THTX – theratechnologies inc. - common shares (US:NASDAQ)
Stock Stats
News
5/2
07:45 am
thtx
Medium
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Financial Post (Toronto, Ontario, Canada)]
5/2
07:44 am
thtx
Medium
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting [Yahoo! Finance]
5/2
07:30 am
thtx
Medium
Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
4/23
02:09 pm
thtx
Low
Theratechnologies (THTX) Upgraded to Buy: What Does It Mean for the Stock? [Yahoo! Finance]
4/15
04:34 pm
thtx
Low
Theratechnologies Announces Mailing of Management Proxy Circular in Connection with its Annual Meeting of Shareholders [Yahoo! Finance]
4/15
09:31 am
thtx
Low
Form 6-K Theratechnologies Inc. For: Apr 15
4/10
08:31 am
thtx
Medium
Form 6-K Theratechnologies Inc. For: Apr 10
4/10
08:17 am
thtx
Medium
Form 6-K Theratechnologies Inc. For: Apr 10
4/5
12:58 pm
thtx
Medium
Form 6-K Theratechnologies Inc. For: Apr 05
3/22
04:27 pm
thtx
Medium
Form 6-K Theratechnologies Inc. For: Mar 22
Show more
Top News Gainers
2/4 Theratechnologies Signs Agreements With Massachusetts General Hospital and Dr. Steven Grinspoon 19.1%
3/3 Theratechnologies Inc. (NASDAQ: THTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity. They now have a $95.50 price target on the stock. 17.7%
4/14 Theratechnologies Announces Financial Results for the First Quarter of 2020 11.8%
10/14 REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV 9.9%
4/16 Theratechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6.8%
10/21 Theratechnologies Provides Details About R&D Day Webcast 4.7%
3/11 Visceral Fat is a Predictor of Liver Fibrosis and Fibrosis Progression in People Living With HIV 3.8%
3/13 Form 6-K Theratechnologies Inc. For: Mar 13 3.4%
1/10 Theratechnologies Inc. (NASDAQ: THTX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.4%
12/19 Form 6-K Theratechnologies Inc. For: Dec 19 2.6%
Top News Decliners
11/15 Form F-10/A Theratechnologies Inc. -12.3%
10/10 Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing  -7.5%
4/15 Theratechnologies Inc. (THTX) Q1 2020 Earnings Call Transcript [The Motley Fool] -5.4%
12/2 Theratechnologies Inc. (NASDAQ: THTX) is now covered by analysts at Canaccord Genuity. They set a "buy" rating on the stock. -5.1%
11/22 Form EFFECT Theratechnologies Inc. -4.1%
3/31 Form 6-K Theratechnologies Inc. For: Mar 31 -3.6%
11/25 Theratechnologies Starts Commercialization of New EGRIFTA SV?? in the United States -2.6%
10/11 Form F-X Theratechnologies Inc. Filed by: Theratechnologies Inc. -2.0%
2/18 Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019 -1.8%
3/10 Form 6-K Theratechnologies Inc. For: Mar 10 -1.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3